ISEH Annual Meeting: Young Investigator Programs

ISEH 年会：青年研究者计划

• 批准号: 7573101
• 负责人: Kevin Baliozian
• 金额: $ 0.75万
• 依托单位: INTERNATIONAL SOCIETY/EXPER HEMATOLOGY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-07-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7573101
• 关键词: Autoimmunity; Biology; Boston; Brain Injuries; Cerebrum; Clinical; Development; Diagnosis; Disease; Encephalitis; Ensure; Epigenetic Process; Event; Future; Hematology; Hematopoiesis; Hematopoietic; Immune; Immunity; Immunologic Deficiency Syndromes; Immunology; Individual; Industry; Injury; International; Joints; Learning; Massachusetts; Names; Neonatal; Oral; Participant; Pregnancy; Public Health; Regulation; Research; Research Personnel; Running; Schedule; Science; Scientist; Structure; Transplantation Immunology; abstracting; career; day; experience; insight; oncology; pluripotency; posters; pre-clinical; programs; size; symposium

DESCRIPTION (provided by applicant): Project Summary Abstract The ISEH 37th Annual Scientific Meeting has been scheduled for July 9 -12, 2008 in Boston, Massachusetts. This year's program will bring together over 400 investigators from around the world and at various points in their career for three and a half days of interaction and high-level science. This intimate meeting size makes it very convenient for cross-talk amongst all meeting participants. New this year, we have taken additional steps to ensure that small group discussions are occurring and that our established researchers have the opportunity to share their experiences and insights with the up and coming scientists. We have also created a session structure that will mingle senior research presenters with a presentation from a young investigator. It is our opinion that this new way of structuring a meeting will deliver a powerful educational experience and continue to engage our future scientists in becoming the future leaders of the profession. The 2008 conference topics are current, cutting edge and uniquely presented and have not been discussed at any other conference in the field. Highlights for this year's meeting include: pluripotency, epigenetic regulation of Hematopoiesis, hematopoietic niche, biology of HSCs, developmental Hematopoiesis and immunology to name a few. These sessions will also be complimented with poster and oral abstract presentations. We anticipate receiving over 350 abstract submissions for this year's meeting. New this year, we are very pleased to partner and host a joint meeting with the Neonatal Hematology and Immunology Meeting. This meeting will run as a track within the ISEH Annual Meeting. Session highlights from this track include: dysregulation of neonatal cellular and phagocytic immunity, inflammation and brain damage/cerebral paulsey, autoimmunity, pregnancy and immune-related neonatal injury, and diagnosis and management of primary immunodeficiency syndromes. PUBLIC HEALTH RELEVANCE: Project Narrative The ISEH Annual Scientific Meeting is a premier scientific event, providing an international forum for the exchange of the latest scientific discoveries in experimental, pre-clinical and clinical hematology, transplantation and immunology. Conference attendees are multinational and represent professionals involved in research and science of hematology/oncology diseases, including researchers, scientists, clinicians and industry representatives. This meeting is truly like no other meeting and provides for the perfect forum for individuals from around the world come together to exchange ideas and learn from one another.

ISEH第37届年度科学会议定于2008年7月9日至12日在马萨诸塞州波士顿举行。今年的项目将汇集来自世界各地的400多名研究人员，在他们职业生涯的不同阶段，进行为期三天半的互动和高水平的科学研究。这种亲密的会议规模使得所有与会者之间的相声非常方便。今年，我们采取了额外的措施，以确保小组讨论的进行，并确保我们现有的研究人员有机会与崭露头角的科学家分享他们的经验和见解。我们还创建了一个会议结构，将高级研究报告与年轻研究人员的报告混合在一起。我们认为，这种组织会议的新方式将提供强大的教育体验，并继续吸引我们未来的科学家成为该行业未来的领导者。2008年会议的主题是当前的、前沿的、独特的，并且在该领域的任何其他会议上都没有讨论过。今年会议的亮点包括：多能性、造血表观遗传调控、造血生态位、造血干细胞生物学、发育造血和免疫学等。这些会议还将辅以海报和口头抽象报告。我们预计今年的会议将收到350多份摘要。今年，我们非常高兴与新生儿血液学和免疫学会议合作并主办一次联合会议。本次会议将作为ISEH年会的一个环节。本次会议的重点包括：新生儿细胞和吞噬免疫失调，炎症和脑损伤/脑泡疮，自身免疫，妊娠和免疫相关的新生儿损伤，以及原发性免疫缺陷综合征的诊断和管理。